Sibutramine
Introduction[edit | edit source]
Sibutramine is a pharmacological agent that functions as a serotonin and norepinephrine reuptake inhibitor. Originally designed for the treatment of depression, it was later repurposed and used primarily for the short- and long-term management of obesity. However, in 2010, its usage was withdrawn due to an observed increased risk of cardiovascular events.
Mechanism of Action[edit | edit source]
Sibutramine, chemically referred to as si bue' tra meen, belongs to the beta-phenylethylamine class of compounds. It acts by inhibiting the reuptake of two neurotransmitters in the brain: serotonin and norepinephrine. While it was initially developed to act as an antidepressant, sibutramine exhibited a minimal therapeutic effect on depression. However, an unintended consequence of its administration was weight loss, which researchers linked to decreased appetite and a subsequent reduction in caloric intake.
Relationship with Liver Toxicity[edit | edit source]
In comprehensive clinical trials, the administration of sibutramine did not correlate with elevated serum enzyme levels, indicating a low risk of liver-related side effects. However, on rare occasions, sibutramine has been connected to cases of clinically significant acute liver injury.
FDA Approval and Subsequent Withdrawal[edit | edit source]
The FDA granted approval for sibutramine as an obesity treatment in the United States in 1997. The drug enjoyed widespread prescription until 2010 when emerging research studies demonstrated a concerning association between sibutramine usage and an increased likelihood of experiencing myocardial infarction and stroke. In light of these findings, the drug was officially withdrawn from the market.
Conclusion[edit | edit source]
While sibutramine once showed promise as a treatment for obesity, concerns about its safety profile, particularly regarding cardiovascular events, led to its removal from clinical use. Its history underscores the importance of continued post-market surveillance for all approved medications.
Sibutramine Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Kondreddy Naveen, Prab R. Tumpati, MD